Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells

Published:2005-01-05 Issue:2 Volume:174 Page:800-807
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Vaidya Swapnil V.,Stepp Susan E.,McNerney Megan E.,Lee Jae-Kyung,Bennett Michael,Lee Kyung-Mi,Stewart Colin L.,Kumar Vinay,Mathew Porunelloor A.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference70 articles.

1. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes

2. 2B4, a New Member of the Immunoglobulin Gene Superfamily, Is Expressed on Murine Dendritic Epidermal T Cells and Plays a Functional Role in Their Killing of Skin Tumors

3. Activation of murine epidermal γδ T cells through surface 2B4

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors;Frontiers in Immunology;2024-02-27

2. Receptors of immune cells mediates recognition for tumors;Progress in Molecular Biology and Translational Science;2023

3. Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity;Journal of Experimental & Clinical Cancer Research;2022-02-14

4. CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity;Archives of Pharmacal Research;2021-12-14

5. Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies;ImmunoTargets and Therapy;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3